Published in Pituitary on September 01, 2010
Ectopic acromegaly due to growth hormone releasing hormone. Endocrine (2012) 1.05
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature (1989) 5.03
Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types. Clin Endocrinol (Oxf) (1997) 2.21
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol (2008) 2.08
Real-time detection of Helicobacter Pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy. Endoscopy (2005) 1.97
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost (2012) 1.89
A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet (1994) 1.78
Prenatal diagnosis of thyroid hormone resistance. J Clin Endocrinol Metab (1999) 1.67
Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging (1996) 1.59
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature (1988) 1.52
Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases. Br J Dermatol (2012) 1.51
Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod (2002) 1.47
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest (1994) 1.46
Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab (1973) 1.44
Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab (1997) 1.44
Nucleolar organizer regions in mucinous tumours of the ovary. Histopathology (1990) 1.40
Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation? Clin Endocrinol (Oxf) (2008) 1.38
Do not forget lupus anticoagulant in the era of antiphospholipid antibodies. Nephron (1997) 1.38
Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab (1979) 1.36
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol (2006) 1.30
Evidence of a secondary grapevine domestication centre detected by SSR analysis. Theor Appl Genet (2003) 1.29
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer (2010) 1.25
Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest (2000) 1.23
Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab (1994) 1.15
Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med (1985) 1.14
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature (1979) 1.14
Inappropriate secretion of thyrotropin by the pituitary. Horm Res (1987) 1.12
Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma. Horm Metab Res (2004) 1.12
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (1997) 1.10
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer (2005) 1.10
Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet (1993) 1.09
Management of poor responders in IVF. Reprod Biomed Online (2005) 1.09
Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI. Hum Reprod (2003) 1.08
Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab (2004) 1.08
Serum levels of beta-subunit of chorionic gonadotropin in patients with pituitary tumors. Eur J Endocrinol (1995) 1.07
Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations. J Clin Endocrinol Metab (2000) 1.06
G protein mutations in endocrine diseases. Eur J Endocrinol (2001) 1.05
High plasma thyrotrophin levels in two patients with pituitary tumour. Acta Endocrinol (Copenh) (1972) 1.05
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab (2000) 1.02
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab (1997) 1.01
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia (2009) 1.01
Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies. J Clin Endocrinol Metab (1984) 1.00
Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects. Horm Metab Res (1973) 1.00
Expression and release of intercellular adhesion molecule-1 in renal-cancer patients. Int J Cancer (1995) 0.99
Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology (1993) 0.99
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia (2005) 0.99
Surgical interruption of leptomeningeal drainage as treatment for intracranial dural arteriovenous fistulas without dural sinus drainage. J Neurosurg (1996) 0.99
Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J Clin Endocrinol Metab (2000) 0.98
Evaluation of the efficacy of bentonite from the south of Argentina to ameliorate the toxic effects of aflatoxin in broilers. Poult Sci (2001) 0.97
Acute renal cortical scintigraphy in children with a first urinary tract infection. Pediatr Nephrol (2001) 0.97
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells. Oncogene (2007) 0.97
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab (2001) 0.96
Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization. J Pharm Pharmacol (2004) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Hopes and facts about mild ovarian stimulation. Reprod Biomed Online (2007) 0.96
Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Eur J Endocrinol (2003) 0.96
Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr Res (2000) 0.96
Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab (2002) 0.95
Idiopathic pulmonary hemosiderosis in an adult. Favourable response to azathioprine. Monaldi Arch Chest Dis (2001) 0.95
Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab (2003) 0.95
Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab (2003) 0.95
Progressive myelopathy caused by intracranial dural arteriovenous fistula: report of two cases and review of the literature. Neurosurgery (1993) 0.95
Dopamine inhibits cytosolic Ca2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action. J Biol Chem (1987) 0.93
Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation (1999) 0.93
Failure of oral 5-hydroxytryptohan administration to affect prolactin secretion in man. Horm Res (1976) 0.93
Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab (1999) 0.93
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. Clin Endocrinol (Oxf) (2007) 0.93
Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol (1997) 0.92
Large pituitary hyperplasia in severe primary hypothyroidism. J Clin Endocrinol Metab (2011) 0.92
Increased HK1 activity levels in the red cells of a patient with a de novo trisomy 10p: t(Y;10)(p11;p12). Hum Genet (1979) 0.92
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells. J Endocrinol (1998) 0.92
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment? Eur J Endocrinol (1998) 0.92
Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa. Acta Endocrinol (Copenh) (1976) 0.92
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J Clin Endocrinol Metab (2000) 0.92
Effects of a filter at the mouth on pulmonary function tests. Eur Respir J (1995) 0.92
Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study. Cancer (1996) 0.92
Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. J Endocrinol Invest (1993) 0.92
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. J Clin Endocrinol Metab (2013) 0.92